HTLV-1 associated myelopathy in Canada.

HTLV-1 associated myelopathy in Canada.

We report the clinical and laboratory findings of six Canadian patients with progressive myelopathy associated with HTLV-1 infection. The diagnosis was suspected on clinical grounds and supported by serological studies and positive gene amplification. Only five had emigrated from an area endemic for...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Power, C, Weinshenker, BG, Dekaban, G, Ebers, G, Francis, G, Rice, G
Format:	Journal article
Sprache:	English
Veröffentlicht:	1989

Ähnliche Einträge

ABSENCE OF ANTIBODIES TO HTLV-I AND HTLV-III IN SERA OF PATIENTS WITH MS AND CHRONIC MYELOPATHY
von: Rice, G, et al.
Veröffentlicht: (1986)

Some clinical and pathologic observations on chronic myelopathy: a variant of multiple sclerosis.
von: Weinshenker, BG, et al.
Veröffentlicht: (1990)

Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy.
von: Rice, G, et al.
Veröffentlicht: (1986)

Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.
von: Kevin G Buell, et al.
Veröffentlicht: (2016-01-01)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.
von: Kirk, P, et al.
Veröffentlicht: (2011)

Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy.
von: Felipe von Glehn, et al.
Veröffentlicht: (2012-01-01)

Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy
von: Tomoo Sato, et al.
Veröffentlicht: (2024-10-01)

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
von: Weinshenker, BG, et al.
Veröffentlicht: (1992)

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.
von: Weinshenker, BG, et al.
Veröffentlicht: (1989)

B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy
von: Aowei Lv, et al.
Veröffentlicht: (2024-10-01)

Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
von: Antonio Mastino, et al.
Veröffentlicht: (2011-05-01)

Magnetic resonance imaging in HTLV-I associated myelopathy
von: Aílton Melo, et al.
Veröffentlicht: (1993-09-01)

HTLV-I associated myelopathy in salvador (northeastern Brazil)
von: A. Meireles, et al.
Veröffentlicht: (1992-06-01)

Galvanic vestibular stimulation for the postural rehabilitation of HTLV-1-associated myelopathy
von: Tatiana Rocha Silva, et al.
Veröffentlicht: (2024-12-01)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
von: Alvaro Schwalb, et al.
Veröffentlicht: (2020-06-01)

Diffusion tensor imaging metrics in diagnosis of HTLV‐1‐associated myelopathy
von: Sheila N. F. Liberato de Matos, et al.
Veröffentlicht: (2022-04-01)

Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
von: Reza Boostani, et al.
Veröffentlicht: (2019-05-01)

Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis
von: Naiane Araújo Patrício, et al.
Veröffentlicht: (2020-11-01)

Systemic interferon alfa in multiple sclerosis.
von: Weinshenker, BG, et al.
Veröffentlicht: (1989)

The natural history of multiple sclerosis.
von: Weinshenker, BG, et al.
Veröffentlicht: (1987)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
von: Satoshi Nozuma, et al.
Veröffentlicht: (2017-04-01)

An open trial of OKT3 in patients with multiple sclerosis.
von: Weinshenker, BG, et al.
Veröffentlicht: (1991)

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
von: Jeffery, K, et al.
Veröffentlicht: (1999)

Immunologic parameters of cerebrospinal fluid in HTLV-I associated myelopathy
von: Marzia Puccioni-sohler
Veröffentlicht: (1995-06-01)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
von: Taylor Graham P, et al.
Veröffentlicht: (2011-06-01)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
von: Stumpf Michael PH, et al.
Veröffentlicht: (2011-10-01)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
von: Satoshi Nozuma, et al.
Veröffentlicht: (2016-01-01)

Cognitive impairment in HTLV-1-associated myelopathy, proviral load and inflammatory markers
von: Ana Paula Silva Champs, et al.
Veröffentlicht: (2019-07-01)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene
von: Antonio C. R. Vallinoto, et al.
Veröffentlicht: (2015-01-01)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
von: Akihito Koseki, et al.
Veröffentlicht: (2023-06-01)

HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients
von: Rosa Maria do Nascimento Marcusso, et al.
Veröffentlicht: (2024-05-01)

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
von: Marco Baratella, et al.
Veröffentlicht: (2017-01-01)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
von: Yoshimi Enose-Akahata, et al.
Veröffentlicht: (2019-11-01)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Overlapping Ossification of the Ligamentum Flavum
von: Guilherme Gago, et al.
Veröffentlicht: (2020-09-01)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
von: Reza Boostani, et al.
Veröffentlicht: (2016-05-01)

Caracterização molecular do HTLV-1 em pacientes com paraparesia espástica tropical/mielopatia associada ao HTLV-1 em Belém, Pará Molecular characterization of HTLV-1 among patients with tropical spastic paraparesis/HTLV-1 associated myelopathy in Belém, Pará
von: Lucinda A. Souza, et al.
Veröffentlicht: (2006-10-01)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
von: Houshang Rafatpanah, et al.
Veröffentlicht: (2013-03-01)

Use of Oral Corticosteroids to Treat HTLV-1-Associated Myelopathy (HAM) in São Paulo, Brazil
von: Flavia Esper Dahy, et al.
Veröffentlicht: (2023-05-01)

Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients
von: Larissa Deadame de Figueiredo Nicolete, et al.
Veröffentlicht: (2012-09-01)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
von: Shuntaro Tsutsumi, et al.
Veröffentlicht: (2019-10-01)